ArticleBMC complementary medicine and therapies2025
Integrative investigation on Hippocratea africana root: insights from cardio-protective, anti-oxidative stress activities, isolation, GC/MS, and pharmacological significance profiling.
Article in BMC complementary medicine and therapies, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Anti-inflammatory and anti-bacterial potentials of Caryota mitis L. leaves extract in urothelial LPS-induced inflammation and UTI pathogens.Archives of microbiology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundHippocratea africana root is scientifically used in cardiotoxicity treatment; therefore, this study was designed to validate this claims through the evaluation of its cardioprotective activity, isolation, and characterization of its constituents, as well as in silico profiling of these ligands against antioxidant enzymes.
methodsStandard protocols were followed in the extraction, fractionation, isolation, characterization, evaluation of cardio-protective activity (marker enzymes, oxidative stress markers, and histological section), retrieval of target proteins (SOD, CAT, GPx, and GSH), ADMET, and docking studies. Column and thin layer chromatography as well as GC/MS aided the isolation and characterization of compounds; SWISSADME and ADMET lab 2 enhanced the evaluation of pharmacokinetic properties; PyRx for docking analysis; Biovia discovery studio and PyMol software for 2D and 3D visualization of the ligand-protein interactions.
resultsThe root extract administration significantly (p < 0.05) reduced the serum levels of CK-MB, LDH, and troponin I that were elevated after doxorubicin administration; however, the levels of GSH, GST, SOD, GPx, and CAT that were decreased after doxorubicin administration were significantly (p < 0.05) elevated whereas the raised MDA level was reduced after treatment with the extract and fractions of the plant. Also, the histological sections in the extract-treated rats showed reductions in pathological features as compared with the negative control group. Moreover, the chemical pathological changes were consistent with histopathological observations suggesting marked cardio-protective potentials. Furthermore, the chromatographic analyses yielded bulked fractions {D3 (11 mg), E6 (25 mg), and E8 (21 mg)} and their GC/MS analyses revealed dihydroartemisinin; retinoic acid, methyl ester; α-thujene; α-terpinolene; 9,12,15-octadecatrienal; α-terpineol etc. with already reported antioxidant activities. These ligands (dihydroartemisinin; retinoic acid, methyl ester) obeyed Lipinski's criteria, had remarkable pharmacokinetic profiles, and their docking analyses revealed that they modulated antioxidant enzymes with better binding affinities than vitamin C.
conclusionGiven the demonstrated antidotal and cardioprotective properties of the plant root, it presents a promising candidate for mitigating doxorubicin-induced toxicities and could be effectively utilized as a supportive therapy in such contexts.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.